Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024

SELL
$29.97 - $36.66 $53,196 - $65,071
-1,775 Reduced 96.73%
60 $1.94 Million
Q2 2021

Jul 17, 2024

BUY
$25.39 - $32.61 $45,067 - $57,882
1,775 Added 2958.33%
1,835 $60,000
Q1 2019

Jul 17, 2024

BUY
$26.93 - $34.7 $1,615 - $2,082
60 New
60 $1.99 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.4B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.